Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Galmed Pharmaceuticals Ltd. (GLMD)

« Back to company index

GLMD Chatter Timeline

Stock Ticker for GLMD

Most Active Tweeters for GLMD

UserTweets
@AmericanBanking 6
@Miljenkoz 4
@techwhitepapers 4
@ZolmaxNews 4
@ConsumerFeed 4

Recent Tweets for GLMD

SiteFocusHQ @SiteFocusHQ
$GLMD Earnings Intelligence Analysis of recent earnings identified Galmed Pharmaceuticals Ltd. (GLMD) business focu… https://t.co/aU0CXnNnGA
November 10th 2019, 11:11am
BlueBioNow @BlueBioNow
$GLMD Always buy on Fear ..?????????????? -3.66 % change recently https://t.co/NBRHpPSfCE
November 10th 2019, 10:11am
SeekingAlpha @SeekingAlpha
$GLMD - Galmed Pharmaceuticals Ltd (GLMD) CEO Allen Baharaff on Q3 2019 Results - Earnings Call Transcript. Sign up… https://t.co/74Lstwfc5p
November 10th 2019, 8:11am
AmericanBanking @AmericanBanking
Galmed Pharmaceuticals Ltd $GLMD Receives Average Rating of “Buy” from Analysts https://t.co/gXiRn7pEbK #stocks
November 10th 2019, 1:11am
ZolmaxNews @ZolmaxNews
Galmed Pharmaceuticals Ltd $GLMD Receives Average Rating of “Buy” from Analysts https://t.co/oex2VAh1C9
November 10th 2019, 1:11am
OlympiaReport @OlympiaReport
Galmed Pharmaceuticals $GLMD Posts Earnings Results, Beats Expectations By $0.11 EPS https://t.co/dYYExJGZW7
November 10th 2019, 12:11am
WeekHerald @WeekHerald
Galmed Pharmaceuticals $GLMD Releases Earnings Results https://t.co/zZpDaGn2rA
November 10th 2019, 12:11am
dispatchtribune @dispatchtribune
Galmed Pharmaceuticals $GLMD Posts Earnings Results, Beats Expectations By $0.11 EPS https://t.co/1i1EnAeEpo
November 10th 2019, 12:11am
dakotafinancial @dakotafinancial
Galmed Pharmaceuticals $GLMD Releases Quarterly Earnings Results, Beats Expectations By $0.11 EPS https://t.co/D57Swzd2y2
November 10th 2019, 12:11am
ThisLincolnian @ThisLincolnian
Galmed Pharmaceuticals $GLMD Issues Earnings Results, Beats Estimates By $0.11 EPS https://t.co/K30IMJY1lK
November 10th 2019, 12:11am
ConsumerFeed @ConsumerFeed
Galmed Pharmaceuticals $GLMD Issues Earnings Results, Beats Estimates By $0.11 EPS https://t.co/LFkDOvXY7l
November 9th 2019, 11:11pm
bbnsnews @bbnsnews
Galmed Pharmaceuticals $GLMD Announces Quarterly Earnings Results, Beats Expectations By $0.11 EPS https://t.co/0iUHhsOA45
November 9th 2019, 11:11pm
AmericanBanking @AmericanBanking
Galmed Pharmaceuticals $GLMD Posts Earnings Results, Beats Estimates By $0.11 EPS https://t.co/yYaZnHgZX2 #stocks
November 9th 2019, 7:11pm
ZolmaxNews @ZolmaxNews
Galmed Pharmaceuticals $GLMD Issues Earnings Results https://t.co/TBa7xRnGLE
November 9th 2019, 7:11pm
dailypoliticaln @dailypoliticaln
Galmed Pharmaceuticals $GLMD Posts Earnings Results, Beats Estimates By $0.11 EPS https://t.co/34d8OrReGd
November 9th 2019, 7:11pm
gcassidy718 @gcassidy718
$GLMD "Everything is impossible until someone does it" -2.75 % change recently https://t.co/EBd4rufLdZ
November 8th 2019, 8:11pm
techwhitepapers @techwhitepapers
@Miljenkoz few months ago and yet to be fully disclosed $GLMD has licensed or bought a new mode of action anti infl… https://t.co/UlP68D2ocy
November 8th 2019, 11:11am
techwhitepapers @techwhitepapers
@Miljenkoz as it is $GLMD Aramchol has shown great efficacy in #nash and having twice a day dozing will just make i… https://t.co/lzzJDXwmxV
November 8th 2019, 11:11am
Miljenkoz @Miljenkoz
@techwhitepapers <to achieve total domination of the #nash space> please, can you expand on that *a-inflammatory drug*? $GLMD
November 8th 2019, 11:11am
techwhitepapers @techwhitepapers
$GLMD has acquired an anti inflammatory drug that will most likely combine with Aramchol to achieve total dominatio… https://t.co/lOQkcO9kfr
November 8th 2019, 11:11am
ConsumerFeed @ConsumerFeed
Galmed Pharmaceuticals $GLMD Stock Rating Lowered by ValuEngine https://t.co/P2ihteyMEr
November 8th 2019, 1:11am
bbnsnews @bbnsnews
Galmed Pharmaceuticals $GLMD Stock Rating Lowered by ValuEngine https://t.co/2o3uUckvnq
November 8th 2019, 1:11am
AmericanBanking @AmericanBanking
Maxim Group Reiterates Buy Rating for Galmed Pharmaceuticals $GLMD https://t.co/0VcOybq4Fi #stocks
November 7th 2019, 4:11pm
EnterpriseLeade @EnterpriseLeade
Galmed Pharmaceuticals’ $GLMD “Buy” Rating Reaffirmed at Maxim Group https://t.co/KJfc1tHn8l
November 7th 2019, 4:11pm
dispatchtribune @dispatchtribune
Galmed Pharmaceuticals’ $GLMD “Buy” Rating Reaffirmed at Maxim Group https://t.co/YM3xaYsalc
November 7th 2019, 4:11pm
SwingTradeBot @SwingTradeBot
Fell Below 50 DMA today: $GTX $GLMD ... https://t.co/j2lcQOTpfA
November 6th 2019, 2:11pm
StockNewsNow @StockNewsNow
$GLMD Galmed Pharmaceuticals Provides Business Update and Reports Third Quarter 2019 Financial Results https://t.co/h1lhZpRKkq
November 6th 2019, 11:11am
Miljenkoz @Miljenkoz
$GLMD Again they wrote bullshit in their Q-ly report!
November 6th 2019, 10:11am
Stock_News_Now @Stock_News_Now
$GLMD: New SEC Filing for GLMD: Form 6-K (No. 0001104659-19-060261): https://t.co/IsPh62Afle
November 6th 2019, 7:11am
StockTexts @StockTexts
$GLMD Galmed Pharmaceuticals Ltd. SEC Filing: Form 6-K https://t.co/Wjj0oeygkQ
November 6th 2019, 7:11am
otcdynamics @otcdynamics
$GLMD Galmed Pharmaceuticals Provides Business Update and Reports Third Quarter 2019 Financial Results https://t.co/XQEedyDOza
November 6th 2019, 7:11am
newsfilterio @newsfilterio
Galmed EPS beats by $0.09 $GLMD https://t.co/u41r4st3Ah
November 6th 2019, 7:11am
MarketCurrents @MarketCurrents
$GLMD - Galmed EPS beats by $0.09 https://t.co/9y3V3kvUET
November 6th 2019, 7:11am
TheMarketsDaily @TheMarketsDaily
Galmed Pharmaceuticals $GLMD Scheduled to Post Earnings on Wednesday https://t.co/Jr0QlhiccP
November 5th 2019, 2:11pm
stocknewstimes @stocknewstimes
Galmed Pharmaceuticals $GLMD Scheduled to Post Earnings on Wednesday https://t.co/7EMmBrc8LQ
November 5th 2019, 2:11pm
WatchlistN @WatchlistN
Analysts’ Weekly Ratings Changes for Galmed Pharmaceuticals $GLMD https://t.co/UkwKB1vQhV
November 4th 2019, 1:11am
AmericanBanking @AmericanBanking
Analysts’ Weekly Ratings Changes for Galmed Pharmaceuticals $GLMD https://t.co/qPkGE1R7hh #stocks
November 4th 2019, 1:11am
TickerReport @TickerReport
Analysts’ Weekly Ratings Changes for Galmed Pharmaceuticals $GLMD https://t.co/fWauo1IfQE
November 4th 2019, 1:11am
gcassidy718 @gcassidy718
$GLMD Enjoy the weekend everyone! Cheers! ???? 9.09 % change recently https://t.co/EBd4rufLdZ
November 3rd 2019, 12:11pm
BlueBioNow @BlueBioNow
$GLMD blockbuster 9.09 % change recently https://t.co/NBRHpPSfCE
November 2nd 2019, 2:11pm
TickerReport @TickerReport
Galmed Pharmaceuticals $GLMD Shares Up 13% https://t.co/gIaa4lyj8e
November 2nd 2019, 12:11pm
dailypoliticaln @dailypoliticaln
Galmed Pharmaceuticals $GLMD Shares Up 13% https://t.co/cFXjzF8413
November 2nd 2019, 12:11pm
TickerReport @TickerReport
Galmed Pharmaceuticals $GLMD Downgraded by Zacks Investment Research https://t.co/ZzDEd5TVGT
November 2nd 2019, 11:11am
dailypoliticaln @dailypoliticaln
Galmed Pharmaceuticals $GLMD Downgraded by Zacks Investment Research https://t.co/l2DWvmouyC
November 2nd 2019, 11:11am
TheMarketsDaily @TheMarketsDaily
Galmed Pharmaceuticals $GLMD Downgraded by Zacks Investment Research https://t.co/azTA7fihyO
November 2nd 2019, 10:11am
dispatchtribune @dispatchtribune
Galmed Pharmaceuticals $GLMD Downgraded by Zacks Investment Research https://t.co/Fp29umrg2F
November 2nd 2019, 10:11am
ZolmaxNews @ZolmaxNews
Galmed Pharmaceuticals Ltd $GLMD Sees Significant Growth in Short Interest https://t.co/rhcimjIn1k
November 2nd 2019, 4:11am
Miljenkoz @Miljenkoz
@techwhitepapers They need to clarify P3/4, and what is going on! $GLMD
November 1st 2019, 1:11pm
techwhitepapers @techwhitepapers
@Miljenkoz there are many more reasons than even the ones given. there are many things $glmd is doing these days .
November 1st 2019, 11:11am
Miljenkoz @Miljenkoz
I am not complaining about recent $GLMD move, but please, can someone explain rationale?
November 1st 2019, 11:11am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.